임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
53건 표시
- 2상모집 중· Upper Limb Essential TremorStudy of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
리드: 애브비
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL)Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
리드: 아스트라제네카 · 협력: 애브비, 로슈
- 2상모집 중· Lung Non-Small Cell CarcinomaTelisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
협력: 애브비
- 2상모집 중· Idiopathic Pulmonary FibrosisStudy of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
리드: 애브비
- 2상모집 중· Major Depressive DisorderA Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
리드: 애브비
- 2상모집 중· Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients
협력: 애브비
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
협력: 애브비
- 2상모집 중· Small Cell Lung CancerA Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
리드: 애브비
- 2상모집 중· Epithelial Ovarian CancerA Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
리드: 애브비
- 2상모집 중· Waldenstrom MacroglobulinemiaA Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
협력: 애브비, 일라이 릴리
- 2상모집 중· Marginal Zone LymphomaEpcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)
협력: 애브비
- 2상모집 중· Bipolar I or II DisorderStudy to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
리드: 애브비
- 2상모집 중· Primary CNS Lymphoma (PCNSL)Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab
협력: 애브비
- 2상모집 중· Intensive Chemotherapy UnfitAlternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
협력: 애브비
- 2상모집 중· Rheumatoid ArthritisA Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
리드: 애브비
- 2상모집 중· Advanced High-Grade Epithelial Ovarian CancerA Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
리드: 애브비
- 2상모집 중· Generalized Anxiety Disorder (GAD)Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
리드: 애브비
- 2상모집 중· Psoriatic ArthritisStudy of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
리드: 애브비
- 2상모집 중· Waldenstrom MacroglobulinemiaEfficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
협력: 애브비, 화이자
- 2상모집 중· T-cell Acute Lymphoblastic LeukemiaAdding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
협력: 애브비
- 2상모집 중· Locally Advanced Unresectable or Metastatic Gastric AdenocarcinomaA Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
리드: 애브비
- 2상모집 중· Relapsed or Refractory Acute Myeloid Leukemia (AML)BCL2i CLAG-M in R/R Acute Myeloid Leukemia
협력: 애브비
- 2상모집 중· Acute Myeloid LeukemiaDiscontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
협력: 애브비
- 2상모집 중· Gram-negative Bacterial InfectionA Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
리드: 화이자 · 협력: 애브비
- 2상모집 중· Relapsed/Refractory Large B-cell LymphomaMRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma
협력: 애브비
- 2상모집 중· Acute Myeloid LeukemiaVenetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
협력: 애브비
- 2상모집 중· Ovary CancerAn Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
협력: 애브비
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL)Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
리드: 애브비 · 협력: 로슈
- 2상모집 중· Acute Myeloid LeukemiaAzacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
협력: 애브비
- 2상모집 중· Endometrial CancerEvaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
협력: 애브비
- 2상모집 중· Irritable Bowel SyndromeStudy to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
리드: 애브비
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL)A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
리드: 애브비
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.